|
|
|
| Reply to: IL-26 and the prognosis of hepatocellular carcinoma after
resection |
| Zhi-Feng Xi, Seogsong Jeong, Qiang Xia ∗ |
Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China
∗ Corresponding author.
E-mail address: xiaqiang@shsmu.edu.cn (Q. Xia). |
|
|
|
|
Abstract We thank Dr. Braillon for the thoughtful remarks regarding prognostic impact of interleukin (IL)−26 on patients with hepatocellular carcinoma (HCC) undergoing surgical resection [1]. This study drew a conclusion that relative high expression of IL-26 is an independent prognostic factor for HCC patients after resection. The raised concern regarding prospective confirmation is one of the most common underlying limitations of retrospective studies. In addition, a limited number of patients is an important determinant of power. Therefore, validation studies are warranted in the future.
|
|
|
|
|
|
| [1] |
Jin LM, Zhang YH, Zhang CW, Wu WD, Wu J, Dou CW, Wei FQ, Wang ZF, Hu ZM, Zheng SS. Is laparoscopic radical cholecystectomy an effective and safe approach for advanced gallbladder cancer?[J]. Hepatobiliary Pancreat Dis Int, 2020, 19(3): 203-204. |
|
|
|
|
2019, Vol. 18 
